We have a cure in phase one testing. Influenza vaccines — As part of its collaboration with external agencies such as the Bill & Melinda Gates Foundation Global Health Initiative and the US Department of Defense Advanced Research Projects Agency, subunit vaccines for avian influenza (H5N1) and pandemic influenza (H1N1) have been created and advanced into human safety and immunogencity clinical studies. These vaccines consist of the viral hemagglutinin (HA) antigen, which is known to produce a protective immune response in humans.
Its a long hold and cycle. I don't think we can go wrong here. MAN you got my initials and name.
These oil stocks are all up 8% today and another 10 to 20 % before FRIDAY !!!!!!!!!!!!! The momentum is very strong and building. These will have every day trader that has any #$%^&*( betting a double......... The shorts are looking at selling about 10 dollars!
YES , I am riding the rocket with AXAS NOG DNR and TPLM also..................... I loaded the boat and I am very happy this morning............ This is picking up momentum
is on the launch pad..... It will pop 500% like many of the other BIOTECHs did the last two years JAZZ went from 11$ to 162. ICPT 40$ to 450. REGN 20 to to 400$, VRTX 25 to 112, CELG 25$ to 112, ALNX 25 to 25$$$$, PCYC from a mere 5$ to 150 !!!!!!!!!!!!! ACT a favorite went from 35$ to 260...... A 500% return on these stocks happens all the time in the new biotechnology age. IBIO belongs there............... Why can iBio produce influenza vaccines faster than companies that use chicken eggs?
iBio’s process is not dependent on being able to culture live viruses, to genetically engineer cell lines, or to produce large volumes of sterile starting material. Using the iBioLaunch™ platform, a vaccine target can be produced in less than three weeks because the gene engineering process and the protein production processes are inherently faster than virus production in chicken eggs …. BARDA –National defense and players in the future- generally, to develop flexible manufacturing capabilities to allow them to produce countermeasures against chemical, biological, radiological, and nuclear threats. *** Most believe these are our national initiatives and will be used. Under the "task order" issued on Thursday by the Biomedical Advanced Research and Development Authority (BARDA), a state-of-the-art manufacturing center in Texas will submit plans for manufacturing ZMapp, said Dr. Brett Giroir, chief executive officer of Texas A&M Health Science Center, which houses the lab. The lab works in conjunction with Britain's GlaxoSmithKline Plc.
What you are to stupid to know who GATES IS ????? ASPIRE and Eastern have showed you the money..... Time and time again you cant read the White House statement or Robinson director fact sheets... * The existence of ZMAPP and the request to ramp its production is evidence to institutional investors and big pharma of the potential to produce game changing biotherapeutics/vaccines through plant methodology. ** The savings to government expenditure alone would be measured in the billions. ZMAPP has already been acknowledged as one of the most promising treatments available for Ebola. The president has provided extra funding for tobacco and animal antibody solutions. This was in the BARDA Directors (Robinson) testimony on page 7&8 we have heard about on the boards. *****Barriers broke- To date there have been no FDA approved plant-made pharmaceuticals (PMPs). This has made a barrier to entry for iBio and any other companies focused on PMP production. ZMAPP is a game changer… ** IBIO with other companies will benefit from Ebola and many diseases. Its not all or none ** IBIO is a technology platform research company w/without ebola- iBio would return to business as usual prior to Ebola crisis ** If any one of their many catalysts come to fruition their valuation can easily meet at least 250 million market cap in the short term. **) Many successes, rapid fire test , DARPA, Caliber, Novici, GE, GATES history, partners, patents and defense contracts. ** huge markets measured in billions *** In every bubble , outside of a rare few companies having a true groundbreaking catalyst during the cycle, they inevitably fall dramatically and others have the technology and ability to make a difference- CHANGING THE GAME = The ZMAPP use
very nice as IBIO could become a well funded company very soon. They were created for this type of event. Years have went into the platform and technologies. the mutations and remnants of the disease could pop up over and over.
That's kinda funny as only a chimp will jump in front of a train when news hits and the contracts signed. $5.4 Billion Ebola Funding and this is a part of the puzzle................
Nice- conrad from international institute of health, all who has pulled principles here today to be with us. We have pulled together a very impressive assembly of speakers on a very important topic today. We're very grateful to them for joining us. Dr. Anthony fire chief, director of the national institute of allergy and infectious diseases. A representative from glaxosmithkline, chairman of vaccines. Global therapeutic area head. Infectious diseases and vaccines. Research and development of johnson & johnson pharmaceutical company and your lee gerba dean, president of mark vaccines, former director of cdc. Director of policy and analysis at the access campaign.
He will always be a basher no matter the PPS. We have the big chance for the upside.
not a bad entry for a tree climber